We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$12.7B
Cap. Flow %
-6.33%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,430
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.53%
2 Financials 4.78%
3 Healthcare 3.89%
4 Industrials 3.6%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GASS icon
8601
StealthGas
GASS
$329M
$56K ﹤0.01%
+16,032
New +$51.3K
KWY
8602
Kingsway Corp
KWY
$265M
$56K ﹤0.01%
+18,075
New +$43.1K
AIOS
8603
AIOS Tech
AIOS
$39.6M
$56K ﹤0.01%
296
+169
+133% +$30.1K
OCSL icon
8604
PUT
Oaktree Specialty Lending
OCSL
$1.05B
$56K ﹤0.01%
3,600
-133
-4% -$1.98K
MARK
8605
CALL
DELISTED
Remark Holdings, Inc.
MARK
$56K ﹤0.01%
3,020
-1,760
-37% -$35.8K
FRTX
8606
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$56K ﹤0.01%
149
+63
+73% +$21.1K
AGEN
8607
Agenus
AGEN
$326M
$55K ﹤0.01%
940
-7,994
-89% -$496K
ALTO icon
8608
PUT
Alto Ingredients
ALTO
$377M
$55K ﹤0.01%
56,200
+40,000
+247% +$47K
ASRT
8609
PUT
DELISTED
Assertio
ASRT
$55K ﹤0.01%
182
-305
-63% -$78.7K
WKHS icon
8610
Workhorse Group
WKHS
$34M
$55K ﹤0.01%
30
+12
+67% +$31.4K
ACHV icon
8611
Achieve Life Sciences
ACHV
$649M
$54K ﹤0.01%
+831
New +$33.6K
FET icon
8612
PUT
Forum Energy Technologies
FET
$795M
$54K ﹤0.01%
+530
New +$58.3K
ONCY
8613
Oncolytics Biotech
ONCY
$92.5M
$54K ﹤0.01%
+29,520
New +$59.8K
RETO icon
8614
ReTo Eco-Solutions
RETO
$24.6M
0
UAN icon
8615
CVR Partners
UAN
$1.33B
$54K ﹤0.01%
1,376
-748
-35% -$28.5K
CLUB
8616
CALL
DELISTED
Town Sports International Holdings, Inc.
CLUB
$54K ﹤0.01%
+11,400
New +$65K
CORV
8617
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$54K ﹤0.01%
17,214
+2,015
+13% +$6.52K
NL icon
8618
NLI Holdings
NL
$289M
$53K ﹤0.01%
13,590
-958
-7% -$3.92K
PRPH
8619
DELISTED
ProPhase Labs
PRPH
$53K ﹤0.01%
+1,759
New +$54.2K
SUP
8620
PUT
DELISTED
Superior Industries International
SUP
$53K ﹤0.01%
11,100
-11,900
-52% -$63.7K
CSCI
8621
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$53K ﹤0.01%
+113
New +$43.9K
ATHX
8622
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$53K ﹤0.01%
1,424
-344
-19% -$13.2K
MLNT
8623
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$53K ﹤0.01%
14,790
-363
-2% -$1.97K
IBRX icon
8624
ImmunityBio
IBRX
$7.49B
$52K ﹤0.01%
32,671
+5,618
+21% +$7.05K
STKL
8625
CALL
DELISTED
SunOpta
STKL
$52K ﹤0.01%
14,900
-11,700
-44% -$45.3K

Similar funds

Citadel Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.

  • Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.